CG Oncology (CGON) Institutional Ownership $35.91 +0.38 (+1.07%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for CG Oncology (NASDAQ:CGON)CurrentInstitutional OwnershipPercentage26.56%Number ofInstitutional Buyers(last 12 months)27TotalInstitutional Inflows(last 12 months)$722.43MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$25.48M Get CGON Insider Trade Alerts Want to know when executives and insiders are buying or selling CG Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CGON Institutional Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here CG Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/30/2024 Amalgamated Bank1,621$61K0.0%+107.6%0.002% 10/3/2024 SG Americas Securities LLC17,595$664K0.0%N/A0.026% 9/16/2024Point72 Asia Singapore Pte. Ltd.1,209$38K0.0%-75.5%0.002% 8/19/2024Point72 Asset Management L.P.110,410$3.49M0.0%-40.7%0.166% 8/16/2024Perceptive Advisors LLC733,695$23.16M0.6%-43.7%1.101% 8/16/2024Driehaus Capital Management LLC106,951$3.38M0.0%-0.9%0.160% Get the Latest News and Ratings for CGON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CG Oncology and its competitors with MarketBeat's FREE daily newsletter. 8/15/2024Scientech Research LLC8,803$278K0.1%-27.8%0.013% 8/15/2024The Manufacturers Life Insurance Company60,301$1.90M0.0%-5.4%0.090% 8/15/2024Deerfield Management Company L.P. Series C433,540$13.69M0.2%+811.9%0.651% 8/15/2024Point72 Asia Singapore Pte. Ltd.1,209$38K0.0%-75.5%0.002% 8/14/2024Marshall Wace LLP75,982$2.40M0.0%N/A0.114% 8/14/2024Yu Fan1,578,344$49.83M65.1%N/A2.368% 8/14/2024Ally Bridge Group NY LLC174,876$5.52M3.3%-45.4%0.262% 8/14/2024Profund Advisors LLC9,513$300K0.0%N/A0.014% 8/13/2024Ensign Peak Advisors Inc60,565$1.91M0.0%N/A0.091% 8/9/2024Renaissance Technologies LLC43,200$1.36M0.0%+204.2%0.065% 8/9/2024Massachusetts Financial Services Co. MA266,787$8.42M0.0%+2.7%0.400% 8/3/2024TD Asset Management Inc93,084$2.94M0.0%N/A0.140% 8/1/2024Rhumbline Advisers34,229$1.08M0.0%+13.0%0.051% 7/26/2024Bank of New York Mellon Corp89,344$2.82M0.0%+38.4%0.134% 5/17/2024RA Capital Management L.P.1,397,433$61.35M0.8%N/A2.097% 5/16/2024California State Teachers Retirement System2,341$103K0.0%N/A0.004% 5/16/2024Janus Henderson Group PLC1,521,432$66.76M0.0%N/A2.283% 5/16/2024BVF Inc. IL1,884,191$82.72M2.3%N/A2.827% 5/16/2024Blackstone Inc.25,000$1.10M0.0%N/A0.038% 5/15/2024Price T Rowe Associates Inc. MD992,118$43.56M0.0%N/A1.489% 5/15/2024Avoro Capital Advisors LLC700,000$30.73M0.4%N/A1.050% 5/14/2024StemPoint Capital LP40,723$1.79M0.5%N/A0.061% 5/14/2024Decheng Capital LLC5,458,810$239.64M32.1%N/A8.191% 5/14/2024American International Group Inc.306,226$13.44M0.0%N/A0.460% 5/13/2024Ameritas Investment Partners Inc.2,320$102K0.0%N/A0.003% 5/10/2024Vanguard Group Inc.2,225,018$97.68M0.0%N/A3.339% 5/7/2024TimesSquare Capital Management LLC224,073$9.84M0.1%N/A0.336% 5/1/2024Capstone Investment Advisors LLC18,354$806K0.0%N/A0.028% 5/1/2024BNP Paribas Financial Markets11,198$492K0.0%N/A0.017% (Data available from 1/1/2016 forward) CGON Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CGON shares? During the previous two years, 34 institutional investors and hedge funds held shares of CG Oncology. The most heavily invested institutionals were Decheng Capital LLC ($239.64M), Vanguard Group Inc. ($97.68M), BVF Inc. IL ($82.72M), Janus Henderson Group PLC ($66.76M), RA Capital Management L.P. ($61.35M), Yu Fan ($49.83M), and Price T Rowe Associates Inc. MD ($43.56M).Learn more on CGON's institutional investors. What percentage of CG Oncology stock is owned by institutional investors? 26.56% of CG Oncology stock is owned by institutional investors. Learn more on CGON's institutional investor holdings. Which institutional investors have been buying CG Oncology stock? Of the 27 institutional investors that purchased CG Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($5.46M), Vanguard Group Inc. ($2.23M), BVF Inc. IL ($1.88M), Yu Fan ($1.58M), Janus Henderson Group PLC ($1.52M), RA Capital Management L.P. ($1.40M), and Price T Rowe Associates Inc. MD ($992.12K). How much institutional buying is happening at CG Oncology? Institutional investors have bought a total of 17,095,800 shares in the last 24 months. This purchase volume represents approximately $722.43M in transactions. Which CG Oncology major shareholders have been selling company stock? The following institutional investors have sold CG Oncology stock in the last 24 months: Perceptive Advisors LLC ($570.41K), Ally Bridge Group NY LLC ($145.50K), Point72 Asset Management L.P. ($75.83K), Point72 Asia Singapore Pte. Ltd. ($7.45K), The Manufacturers Life Insurance Company ($3.47K), Scientech Research LLC ($3.39K), and Driehaus Capital Management LLC ($1.01K). How much institutional selling is happening at CG Oncology? Institutional investors have sold a total of 807,057 shares in the last 24 months. This volume of shares sold represents approximately $25.48M in transactions. Related Companies Qiagen Institutional Ownership Intra-Cellular Therapies Institutional Ownership Roivant Sciences Institutional Ownership Revolution Medicines Institutional Ownership Legend Biotech Institutional Ownership Viking Therapeutics Institutional Ownership Lantheus Institutional Ownership Ascendis Pharma A/S Institutional Ownership Elanco Animal Health Institutional Ownership Cytokinetics Institutional Ownership This page (NASDAQ:CGON) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CG Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
